Recherche sur le site de l'INESSS

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

GENERAL CONSIDERATIONS This optimal usage guide applies to persons in whom the appropriate microbiological tests have been performed AND whose results show the presence of Chlamydia trachomatis or [...]

1ST CHOICE: ceftriaxone6 500 mg IM as a single dose AND doxycycline3 100 mg PO BID x 7 days 2ND CHOICE: ceftriaxone6 500 mg IM as a single dose OR cefixime 800 mg PO as a single dose AND [...]

1ST CHOICE: ceftriaxone6 500 mg IM as a single dose AND doxycycline3 100 mg PO BID x 7 days 2ND CHOICE: ceftriaxone6 500 mg IM as a single dose OR cefixime 800 mg PO as a single dose AND [...]